Published
Produktion von Lentivirus in GMP-Qualität
Notice number: 00720875-2026
KEY INFORMATION
- Submission deadline
- • Nov 17, 2026
- Location
- 🇩🇪 Germany
- Contracting authority
- Charité - Universitätsmedizin Berlin
- Accepted Languages
- German
- Tender type
- Services
- Contract Value
- Published date
- Oct 19, 2026
TENDER DESCRIPTION
Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, invites bids for the production of lentivirus for the transduction of human cells in GMP quality, including the relevant documentation and a stability study. There are separate requirements under the Berlin Public Procurement and Contracting Act (BerlAVG); see the tender documents. Further information can be found in the documents provided on the Charité procurement platform (https://vergabeplattform.charite.de). Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, invites bids for the production of lentivirus for the transduction of human cells in GMP quality, including the relevant documentation and a stability study. There are separate requirements under the Berlin Public Procurement and Contracting Act (BerlAVG); see the tender documents. Further information can be found in the documents provided on the Charité procurement platform (https://vergabeplattform.charite.de).
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 2 FILES
- Tender detail pageLINK
- TED PortalLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.